211 related articles for article (PubMed ID: 18245516)
1. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
Jpn J Clin Oncol; 2008 Feb; 38(2):106-11. PubMed ID: 18245516
[TBL] [Abstract][Full Text] [Related]
2. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
3. Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney.
Pinthus JH; Kleinmann N; Tisdale B; Chatterjee S; Lu JP; Gillis A; Hamlet T; Singh G; Farrokhyar F; Kapoor A
Eur Urol; 2008 Oct; 54(4):866-73. PubMed ID: 18343565
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of body mass index in Korean patients with renal cell carcinoma.
Jeon HG; Jeong IG; Lee JH; Lee CJ; Kwak C; Kim HH; Lee SE; Lee E
J Urol; 2010 Feb; 183(2):448-54. PubMed ID: 20006879
[TBL] [Abstract][Full Text] [Related]
5. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure.
Tsutamoto T; Tanaka T; Sakai H; Ishikawa C; Fujii M; Yamamoto T; Horie M
Eur Heart J; 2007 Jul; 28(14):1723-30. PubMed ID: 17507366
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system.
Dalamaga M; Karmaniolas K; Nikolaidou A; Chamberland J; Hsi A; Dionyssiou-Asteriou A; Mantzoros CS
Eur J Cancer; 2008 Aug; 44(12):1744-53. PubMed ID: 18515085
[TBL] [Abstract][Full Text] [Related]
7. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.
Kato K; Osawa H; Ochi M; Kusunoki Y; Ebisui O; Ohno K; Ohashi J; Shimizu I; Fujii Y; Tanimoto M; Makino H
Clin Endocrinol (Oxf); 2008 Mar; 68(3):442-9. PubMed ID: 17970779
[TBL] [Abstract][Full Text] [Related]
8. Similar associations of total adiponectin and high molecular weight adiponectin with cardio-metabolic risk factors in a population of overweight and obese postmenopausal women: a MONET study.
Elisha B; Ziai S; Karelis AD; Rakel A; Coderre L; Imbeault P; Rabasa-Lhoret R
Horm Metab Res; 2010 Jul; 42(8):590-4. PubMed ID: 20486084
[TBL] [Abstract][Full Text] [Related]
9. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men.
Seino Y; Hirose H; Saito I; Itoh H
Metabolism; 2009 Mar; 58(3):355-60. PubMed ID: 19217451
[TBL] [Abstract][Full Text] [Related]
10. Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma.
Horiguchi A; Asano T; Asakuma J; Asano T; Sumitomo M; Hayakawa M
J Urol; 2004 Aug; 172(2):718-22. PubMed ID: 15247769
[TBL] [Abstract][Full Text] [Related]
11. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
[TBL] [Abstract][Full Text] [Related]
13. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
Inoue T; Kotooka N; Morooka T; Komoda H; Uchida T; Aso Y; Inukai T; Okuno T; Node K
Am J Cardiol; 2007 Aug; 100(4):569-74. PubMed ID: 17697807
[TBL] [Abstract][Full Text] [Related]
14. Effect of obesity and insulin sensitivity on adiponectin isoform distribution.
Kaser S; Tatarczyk T; Stadlmayr A; Ciardi C; Ress C; Tschoner A; Sandhofer A; Paulweber B; Ebenbichler CF; Patsch JR
Eur J Clin Invest; 2008 Nov; 38(11):827-34. PubMed ID: 19021700
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survival.
Walther MM; Johnson B; Culley D; Shah R; Weber J; Venzon D; Yang JC; Linehan WM; Rosenberg SA
J Urol; 1998 Mar; 159(3):718-22. PubMed ID: 9474133
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction.
Mitsnefes M; Kartal J; Khoury P; Daniels S
Clin J Am Soc Nephrol; 2007 Jan; 2(1):46-50. PubMed ID: 17699386
[TBL] [Abstract][Full Text] [Related]
17. Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome.
Uchida T; Shimizu M; Sakai Y; Nakano T; Hara K; Takebayashi K; Inoue T; Node K; Inukai T; Takayanagi K; Aso Y
Metabolism; 2008 Sep; 57(9):1278-85. PubMed ID: 18702955
[TBL] [Abstract][Full Text] [Related]
18. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
Liang KW; Lee WJ; Lee WL; Ting CT; Sheu WH
Clin Chim Acta; 2009 Jul; 405(1-2):114-8. PubMed ID: 19397903
[TBL] [Abstract][Full Text] [Related]
19. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
20. Total and high molecular weight adiponectin in patients with coronary artery disease.
El-Menyar A; Rizk N; Al Nabti AD; Hassira SA; Singh R; Abdel Rahman MO; Suwaidi JA
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):310-5. PubMed ID: 19430341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
